Researchers report on improved SARS-CoV-2 neutralization assay

In a study published recently in Nature Communications, the developers reported reconfiguring an earlier serological assay that they had developed based on a tri-part split-NanoLuc, a novel bioluminescence platform, to detect antibodies that bind to the SARS-CoV-2 spike protein.

Related Keywords

Toronto ,Ontario ,Canada ,Tim Stenzel ,University Of Toronto ,Nature Communications ,Radiological Health ,Office Of In Vitro Diagnostics ,University Of Utah ,Drug Administration ,Emergency Use Authorizations ,Genscript United States ,Antibody Detection Kit ,Vitro Diagnostics ,